Mueller, Matthias
Novartis (Switzerland) · Novartis Institutes for BioMedical Research
3 papers on CoChatORCID 0000-0002-4299-6497
Most cited papers
- Verified
Disruption of the Mouse mTOR Gene Leads to Early Postimplantation Lethality and Prohibits Embryonic Stem Cell Development
Gangloff, Y.-G., Mueller, M., Dann, S. G., Svoboda, P., Sticker, M., Spetz, J.-F., Um, S. H., Brown, E. J., Cereghini, S., Thomas, G., et al. (2004) · Molecular and Cellular Biology
PI3K/AKT/mTOR signaling in cancerDevelopmental Biology and Gene Regulation
Cited by 485
- Verified
Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy
Risson, V., Mazelin, L., Roceri, M., Sanchez, H., Moncollin, V., Corneloup, C., Richard-Bulteau, H., Vignaud, A., Baas, D., Defour, A., et al. (2009) · Journal of Cell Biology
Muscle Physiology and DisordersPI3K/AKT/mTOR signaling in cancer
Cited by 381
- Verified
The RSPO–LGR4/5–ZNRF3/RNF43 module controls liver zonation and size
Planas-Paz, L., Orsini, V., Boulter, L., Calabrese, D., Pikiolek, M., Nigsch, F., Xie, Y., Roma, G., Donovan, A., Marti, P., et al. (2016) · Nature Cell Biology
Wnt/β-catenin signaling in development and cancerLiver physiology and pathology
Cited by 359
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free